Items in cart [0]
| [ Top of Page ] [ Home ] [ Contact Us ] [ Help ] [ The National Academies Home ] | ||
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 117
APPENDIX D
immunization Safety Review
Committee Biosketches
Marie C. McCormick, M.D., Sc.D., (Chair), is Summer and Esther Feldberg
Professor and Chair of the Department of Maternal and Child Health at the Har-
vard School of Public Health. She received her M.D. degree from Johns Hop-
kins Medical School, and her Sc.D. degree from Johns Hopkins School of Hy-
giene and Public Health. Dr. McCormick is a member of the Institute of
Medicine and has served as chair of the Committee on Preventing Perinatal
Transmission of HIV and the Committee on Prenatal and Newborn Screening
for HIV Infection, and as a member of the Committee on Unintended Preg-
nancy. Her research involves epidemiological and health services research in
areas related to infant mortality and outcomes of high-risk neonates. Her exper-
tise is in pediatrics, maternal and child health policy, and program evaluation.
Ronald Bayer, Ph.D., is Professor in the Division of Sociomedical Sciences at
the Joseph L. Mailman School of Public Health at Columbia University. Dr.
Bayer received his Ph.D. in political science from the University of Chicago.
Since 1982, he has been involved in the study of the ethical and policy dimen-
sions of the AIDS epidemic. He served on the National Research Council's
Committee on the Social Impact of AIDS and, more recently, the Committee on
the Elimination of Tuberculosis in the United States. He is author of numerous
articles on ethical issues posed by AIDS and tuberculosis, including Private
Acts, Social Consequences: AIDS and the Politics of Public Health, and Blood
Feuds: AIDS, Blood, and the Politics of Medical Disaster. His most recent co-
authored book is AIDS Doctors: Voices from the Epidemic.
117
OCR for page 118
118
IMMUNIZA TION SAFETY RE VIE W
Alfred Berg, M.D., M.P.H., is Professor and Chair of the Department of Family
Medicine at the University of Washington School of Medicine. Dr. Berg re-
ceived his M.D. from Washington University and his M.P.H. from the Univer-
sity of Washington. He is a member of the Institute of Medicine. Dr. Berg pres-
ently serves as chair of the third U.S. Preventive Services Task Force and is a
member of the American Academy of Family Physicians and the Society of
Teachers of Family Medicine. He is also an Associate Editor for the Journal of
the American Board of Family Practice. Dr. Berg's research interests include
clinical epidemiology, evidence-based medical practice, preventive medicine,
and clinical practice guidelines.
Rosemary Casey, M.D., is an Associate Professor of Pediatrics at Jefferson
Medical College, and the Director and practicing physician of Lankenau Faculty
Pediatrics. Dr. Casey is board-certified in Pediatrics, and a member of the
American Academy of Pediatrics and the Ambulatory Pediatric Association. She
also serves as editorial consultant on several journals, including Pediatrics, Pe-
diatric Emergency Care, Clinical Pediatrics, and Journal of the Ambulatory
Pediatric Association. Her interests include diagnostic problems and behavioral
pediatrics. Dr. Casey received her M.D. from Harvard Medical School and com-
pleted her residency in pediatrics at the Children's Hospital of Philadelphia. She
was a Robert Wood Johnson Clinical Scholar at the University of Pennsylvania.
Joshua Cohen, Ph.D., is a Senior Research Associate with the Harvard Center
for Risk Analysis. Dr. Cohen received his Ph.D. in Decision Sciences from Har-
vard University. His research includes assessing population risk related to styrene
production and use, and developing a computer model to quantify the risk of bo-
vine spongiform encephalopathy being introduced into the United States and
contaminating the food supply. In addition, he is the project director for a com-
parative evaluation of alternative propulsion systems for heavy-duty urban vehi-
cles. He is the author of a case study conducted for U.S. EPA demonstrating the
application of decision analytical techniques to the evaluation of alternative
drinking water treatment technologies. His research focuses on the application of
decision analytical techniques to environmental risk management problems, with
a special emphasis on the proper characterization and analysis of uncertainty.
Vernice Davis-Anthony, M.P.H., R.N., is Senior Vice President of Corporate
Affairs and Community Health at St. John Health System in Detroit, Michigan,
where she oversees system-wide management and development of community
health policies and programs, strategic planning, marketing and public relations,
and government relations. Ms. Davis-Anthony was the former Director of the
Michigan Department of Public Health, where she achieved the lowest infant
mortality rate in Michigan's history and reduced the teen pregnancy rate in that
state. In addition, Ms. Davis-Anthony established the Michigan Task Force of
OCR for page 119
APPENDIXD: BIOSKETCHES
119
Violence Reduction and Prevention and the Michigan Abstinence Partnership.
She was also appointed to serve as a Governor of Wayne State University. She
received her M.P.H. from the University of Michigan School of Public Health
and Bachelor of Science in Nursing from Wayne State University.
Betsy Foxman, Ph.D., is Professor in the Department of Epidemiology at the
University of Michigan School of Public Health, and Director of the Center for
Molecular and Clinical Epidemiology of Infectious Diseases. Her research fo-
cuses on the combination of epidemiological field methods and modern mo-
lecular techniques to examine the individual and joints effects of host behaviors,
host characteristics, and agent characteristics on disease risk, especially on uri-
nary tract infection, vulvovaginal candidiasis, lactation mastitis, and otitis me-
dia. She serves on various professional organizations, including Chair of the
Epidemiology Division of the American Public Health Association, is a member
of the program committee for the first North American Congress of Epidemi-
ologists, and is a fellow of the Infectious Diseases Society of America. She re-
ceived her Ph.D. in epidemiology from the University of California, Los Ange-
les.
Constantine Gatsonis, Ph.D., is Professor of Medical Science and Applied
Mathematics, and Director of the Center for Statistical Sciences at Brown Uni-
versity. He has served on numerous review and advisory panels, including as a
consultant/ad hoc panel member on the FDA Center for Devices and Radiologi-
cal Health, the Data Safety and Monitoring Board of the VA Cooperative Stud-
ies in Health Services, the Commission of Technology Assessment of the
American College of Radiology, the NINDS Data Safety and Monitoring Board,
and the HCFA Technical Experts Panel. Dr. Gatsonis is the founding editor-in-
chief of Health Services and Outcomes Research Methodology and is on the
editorial board of Academic Radiology, Statistics in Medicine, and Medical De-
cision Making. His research interests include Bayesian inference and its appli-
cations to problems in biostatistics, methodological aspects of health services
and outcomes research, and medical technology evaluation with emphasis on
diagnostic radiology. Dr. Gatsonis received his Ph.D. in mathematical statistics
from Cornell University.
Steven Goodman, M.D., M.H.S., Ph.D., is Associate Professor of Oncology,
Pediatrics, Epidemiology and Biostatistics at the Johns Hopkins Schools of
Medicine and Public Health. Dr. Goodman received his M.D. from New York
University, his M.H.S. and Ph.D. degrees from Johns Hopkins University, and
trained in pediatrics at Washington University in St. Louis. He has been a mem-
ber of two IOM committees: the Committee for a Review of Evidence Regard-
ing the Link Between Exposure to Agent Orange and Diabetes, and the Com-
mittee to Review the Health Effects in Vietnam Veterans of Exposure to
OCR for page 120
120
IMMUNIZA TION SAFETY RE VIE W
Herbicides: Second Biennial Update. As a statistician for the Johns Hopkins
Oncology Center, General Clinical Research Center, and Pediatric Clinical Re-
search Unit, he has participated in the design and analysis of a wide range of
clinical and epidemiological studies. He is co-director of the Johns Hopkins
Evidence-Based Practice Center, and has served as Statistical Editor for the An-
nals of Internal Medicine since 1987. His research interests include meta-
analysis, statistical inference, the ethics of clinical trials, and the use of likeli-
hood and Bayesian methodology in clinical research.
Ellen Horak, M.S.N., is Chief of Local Health Services in the office of Local
and Rural Health at the Kansas Department of Health and Environment. Ms.
Horak is the Past President of the Association of State and Territorial Directors
of Nursing, as well as Past District President of the Kansas State Nurses Asso-
ciation. She is also a member of the American Public Health Association and
Kansas Public Health Association. Ms. Horak received her M.S.N. from the
University of Kansas.
Michael Kaback, M.D., Michael Kaback is Professor of Pediatrics and Repro-
ductive Medicine at the University of California in San Diego. He is an Institute
of Medicine member and has served on previous IOM committees, including the
Committee on Assessing Genetic Risks: Issues and Implications for Health. His
expertise is in medical genetics and pediatrics, and his research interests include
the applications of human genetic technology to treatment and prevention of
hereditary disease and congenital defects, technical, social, psychological, legal,
and ethical implications of new genetic technologies, and public health and
medical practice implications. Dr. Kaback received his M.D. from the Univer-
sity of Pennsylvania School of Medicine.
Gerald Medoff, M.D., is Professor of Medicine and Microbiology and Immu-
nology, and Senior Advisor to the Chairman of the Internal Medicine Depart-
ment at Washington University School of Medicine. He was formerly Head of
the Infectious Disease Division at Washington University School of Medicine.
He has served on various committees, including the Committee on Infectious
Diseases of the American Board of Internal Medicine, the Executive Board of
the AIDS Clinical Trials Unit, and the Pharmacy and Therapeutics Committee of
Blue Cross and Blue Shield. In addition, he was Chairman of the AIDS Re-
search Advisory Committee of the National Institute of Allergy and Infectious
Diseases. Dr. Medoff's research interests include AIDS, fungal diseases, other
infectious diseases, and antimicrobial agents. He received his M.D. from Wash-
ington University School of Medicine.
Rebecca Parkin, Ph.D., M.P.H., is Associate Research Professor at The
George Washington University Medical Center. Dr. Parkin received her Ph.D.
OCR for page 121
APPENDIXD: BIOSKETCHES
121
and M.P.H. from Yale University. She is a former director of scientific, profes-
sional, and section affairs at the American Public Health Association as well as
assistant commissioner for the Division of Occupational and Environmental
Health of the New Jersey Department of Health. She is a member of the Na-
tional Research Council Water Science and Technology Board, and has served
on several NRC committees. She is a liaison member of the DHHS's National
Advisory Committee on Childhood Lead Poisoning Prevention, and a peer re-
viewer for the New Jersey Cancer Research Commission. She continues to serve
on subcommittees of EPA's Science Advisory Board, and has been a member of
study panels of the Agency for Toxic Substance Disease Registry. She is cur-
rently conducting research in the areas of environmental epidemiology, risk as-
sessment, risk perception and communication, and immunization programs.
Bennett A. Shaywitz, M.D., is Professor of Pediatrics and Neurology and Chief
of Pediatric Neurology at the Yale University School of Medicine where he is
also Co-Director of the Yale Center for the Study of Learning and Attention. He
has served on previous IOM committees, including the Committee to Study Fe-
tal Alcohol Syndrome, the Committee on New Research on Vaccines, the
Committee to Review the Adverse Consequences of Pertussis and Rubella Vac-
cines, Committee for a Review of an Epidemiology Study of Neurologic Illness
and Vaccination in Children, and the Committee on Reye's Syndrome and
Medication. Currently, he leads a research group that is using functional mag-
netic resonance imaging (fMRI) to investigate the neural basis of reading and
reading disability (dyslexia). Recently, he and his colleagues have used this
technology to discover differences in brain organization and function in children
and adults with dyslexia, and he has now begun to use fMRI to study how the
brain changes as children with dyslexia are taught to read.
Christopher Wilson, M.D., is Professor and Chair of the Department of Immu-
nology at the University of Washington. He is a fellow of the American Asso-
ciation for the Advancement of Science, the Infectious Diseases Society of
America, and the American Academy of Pediatrics. He was also a member of
the Maternal and Child Health Research Committee of the National Institute of
Child Health and Human Development. His research includes laboratory work
on the elucidation of the molecular mechanisms by which functional differences
between naive and memory/effector T-cells are imposed, thereby allowing them
to exhibit fixed and heritable patterns of effecter functions. In addition, his work
includes addressing mechanisms governing the development of immunity fol-
lowing primary function, in particular with the intracellular pathogens M. tuber-
culosis, Listeria monocytogenes, and herpes simplex virus. Dr. Wilson received
his M.D. from the University of California, Los Angeles.
OCR for page 122
122
Board on Health Promotion Disease Prevention Liaison
IMMUNIZA TION SAFETY RE VIE W
Richard Johnston Jr., M.D., is currently Professor of Pediatrics at the National
Jewish Medical and Research Center at the University of Colorado School of
Medicine. He was formerly the Medical Director of the March of Dimes Birth
Defects Foundation, and Chief of the Section of Immunology in the Department of
Pediatrics at Yale University School of Medicine. Among his previous appoint-
ments is the position of Chairman of Pediatrics, University of Pennsylvania. He is
a member of the Association of American Physicians and the Institute of Medicine
and a Fellow of the American Association for the Advancement of Science. His
publications include work on immune diseases in children and mechanisms of host
defense and inflammation. Dr. Johnston is a past president of the society for Pedi-
atric Research and the American Pediatric Society. He is a member of the Board
on Health Promotion Disease Prevention of the Institute of Medicine and has
chaired four IOM committees, including Multiple Sclerosis: Current Status and
Strategies for the Future, the Assessment of Asthma and Indoor Quality, and the
Vaccine Safety Committee. He has served on several other IOM committees, in-
cluding the Committee to Review Adverse Consequences of Pertussis and Rubella
Vaccines and the Immunology Benchmarking Guidance Group.
Representative terms from entire chapter:
health association